跳至主要内容
临床试验/KCT0002394
KCT0002394招募中未知

Prevention of Post-ERCP Pancreatitis by Intraduodenal Indomethacin in ERCP naïve patients: Prospective, Randomized, Placebo-controlled, Double blind, Multicenter Study

Chung-Ang Univerisity Hospital0 个研究点目标入组 926 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
926

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 80(Year)(—)
性别
All

入选标准

  • 1) Age = 20 or age = 80, 2) Patients with naïve papilla and first ERCP, 3) Diagnostic or therapeutic ERCP, 4) No evidence of significant abnormality in cardiopulmonary function, 5) No expectation of adverse event after indomethacin application.

排除标准

  • 1) Unwillingness or inability to informed consent for study, 2) Age < 20 or > 80, 3) Pregnant women, 4) Lactating women, 5) Clinical contraindication for ERCP, 6) History of allergy or hypersensitivity to aspirin or NSAIDs, 7) Recent history (within 7 days) of NSAIDs medication, 8) Serum creatinine > 1.4 mg/dL, 9) Active or recent (within 4 weeks) gastrointestinal bleeding, 10) Active cardiovascular or cerebrovascular disease, 11) Acute pancreatitis within 72 hours, 12) Chronic pancreatitis, 13) ERCP for stent removal or stent change, 14) Endoscopic sphicterotomy state, 15) Drug or alcohol abuser, 16) Psychiatric illness that anticipated inability to follow study protocol.

研究者

发起方
Chung-Ang Univerisity Hospital

相似试验

Prevention of Post-ERCP Pancreatitis by... | 临床试验